Study Finds Hospitals Reduce Pediatric Patient Length of Stay by 25% by Deploying Etiometry Risk Analytics
News and Press Releases
Results of a Multi-Center, Retrospective Cohort Analysis of All Neonates Admitted to the CICU at Boston Children’s Hospital and the Hospital for Sick Children, Toronto
BOSTON, December 19, 2017—Etiometry, a pioneering leader in next-generation patient monitoring, announced today that a study presented in the American Heart Association (AHA) Scientific Sessions 2017 demonstrates the capability of the Etiometry Platform to significantly reduce hospitals intensive care unit costs.
The Impact of a Real-Time Physiologic Data Analytic Index on Length of Stay in Neonates Following Surgery for Congenital Heart Disease abstract presented results from a retrospective study conducted in the first two hospitals that adopted Etiometry’s Inadequate Delivery of Oxygen (IDO2) Index. The study was co-authored by: Dr. Josh Salvin, Boston Children’s Hospital; Dr. Peter Laussen MBBS FCICM, The Hospital for Sick Children, Toronto; and Dr. Dimitar Baronov, PhD, Etiometry’s CTO. It demonstrates a statistically significant 25% reduction of length of stay (LOS) for the neonates admitted for cardiac intensive care in the two hospitals.
According to Etiometry’s COO Evan Butler, “There is a wide expectation in the clinical community that impactful information technology and actionable data analytics should bring much-needed reduction in hospital costs and improvement in patient outcomes. We are proud to see our Etiometry Platform leading the way in proving these expectations by demonstrating measurable positive impact in an especially vulnerable patient population.”
The Etiometry Platform consists of three software components: T3 Data Aggregation & Visualization, Risk Analytics Algorithms, and Quality Improvement System. They are integrated to support clinical use cases, such as meaningful workflow integration and streamlined measurement of care impact. For more information, send an email to info@etiometry.com and request the Etiometry ROI whitepaper.About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
How Documentation, Length of Stay and Capacity Shape Cardiac Surgery Margins
What four years of CABG data from one cardiothoracic ICU suggest about each. Most patients recover from coronary artery bypass grafting along a familiar path: extubation, vasoactive weaning, transfer to the floor, discharge. For some, the postoperative course brings respiratory failure, acute kidney injury or cardiogenic shock. Those complications shape the patient’s recovery, and they […]
What Continuous Physiologic Data Reveals About Cardiogenic Shock
A retrospective analysis compared cardiogenic shock staging built from charted values with staging built from continuous data. The differences were clinically meaningful. In one patient’s record from the analysis, the chart shows a mean arterial pressure of 71 mmHg, and an hour later, 66 mmHg. Read on their own, the two values suggest a patient […]
When Cardiogenic Shock Goes Undocumented: The Clinical and Financial Cost
A missed or unrecorded diagnosis affects the patient first, and the hospital’s ability to care for the next patient soon after. In a busy cardiac ICU, cardiogenic shock is often managed before it is named. Pressors are titrated, labs are trended and the team responds to what the patient’s physiology is telling them. But the […]